Catalent CTI, Inc. (manufacturing of unpackaged product, quality control)

Ukraine

All drugs from this manufacturer

  • IMBRUVICA

    The drug is used for the treatment of mantle cell lymphoma, chronic lymphocytic leukemia (in both treatment-naïve and previously treated patients), as well as Waldenström macroglobulinemia.

    Dosage form: capsules

    Active substance Dosage
    ibrutinib 140 mg

    ATC: L01XE27